Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology Indian Medical PG Practice Questions and MCQs

Question 101: Which of the following medications is contraindicated in patients with allergy to sulfonamides?

A. Levobunolol
B. Bimatoprost
C. Brinzolamide (Correct Answer)
D. Brimonidine

Explanation: **Explanation:** **Brinzolamide** is a topical Carbonic Anhydrase Inhibitor (CAI) used to reduce intraocular pressure in glaucoma. Chemically, CAIs (including Brinzolamide and Dorzolamide) are **sulfonamide derivatives**. Although administered topically, they undergo systemic absorption. In patients with a known sulfonamide allergy, these drugs can trigger hypersensitivity reactions ranging from mild skin rashes to severe conditions like Stevens-Johnson Syndrome. Therefore, a history of sulfa allergy is a contraindication for their use. **Analysis of Incorrect Options:** * **A. Levobunolol:** This is a non-selective **beta-blocker**. It is contraindicated in patients with asthma, COPD, or bradycardia, but it does not share cross-reactivity with sulfonamides. * **B. Bimatoprost:** This is a **prostaglandin analogue**. Its primary side effects include iris repigmentation, hypertrichosis of lashes, and cystoid macular edema, but it is safe for sulfa-allergic patients. * **C. Brimonidine:** This is a highly selective **alpha-2 adrenergic agonist**. While it frequently causes local follicular conjunctivitis (allergic reaction), it is not a sulfonamide. **High-Yield NEET-PG Pearls:** * **Topical CAIs:** Brinzolamide (suspension, less stinging) and Dorzolamide (solution, more stinging). * **Systemic CAI:** Acetazolamide (Diamox) is also a sulfonamide and carries the same contraindication. * **Mechanism:** CAIs reduce IOP by inhibiting carbonic anhydrase in the ciliary epithelium, thereby decreasing aqueous humor production. * **Cross-Reactivity Rule:** Always screen for sulfa allergy before prescribing CAIs, loop diuretics (Furosemide), or thiazides.

Question 102: What is the maximum safe dose of lignocaine with adrenaline for local blocks in ophthalmic surgeries?

A. 3 mg/kg
B. 5 mg/kg
C. 7 mg/kg (Correct Answer)
D. 10 mg/kg

Explanation: **Explanation:** The maximum safe dose of local anesthetics is a high-yield topic in both Ophthalmology and Anesthesia. The dosage depends primarily on whether a vasoconstrictor (like adrenaline) is added to the solution. **1. Why 7 mg/kg is correct:** Lignocaine (Lidocaine) is an amide-type local anesthetic. When used **with adrenaline** (typically 1:100,000 or 1:200,000 concentration), the adrenaline causes local vasoconstriction. This slows down the systemic absorption of the drug, reduces peak plasma levels, and prolongs the duration of the block. This decreased rate of absorption allows for a higher safe threshold, which is **7 mg/kg**. **2. Analysis of Incorrect Options:** * **3 mg/kg (Option A):** This is significantly below the safe threshold for lignocaine and is not a standard limit for this drug. * **5 mg/kg (Option B):** This is the maximum safe dose for **plain lignocaine** (without adrenaline). Without a vasoconstrictor, the drug is absorbed more rapidly into the systemic circulation, increasing the risk of systemic toxicity (LAST). * **10 mg/kg (Option D):** This dose exceeds the safety limit for lignocaine and carries a high risk of Central Nervous System (CNS) and cardiovascular toxicity. **3. Clinical Pearls for NEET-PG:** * **Maximum Absolute Dose:** Regardless of weight, the total dose of lignocaine with adrenaline should generally not exceed **500 mg** in an adult. * **Ophthalmic Context:** In ophthalmic blocks (Peribulbar/Retrobulbar), a mixture of Lignocaine (2%) and Bupivacaine (0.5%) is often used. Bupivacaine provides a longer duration of action but has a lower safety margin (**2 mg/kg**). * **Hyaluronidase:** Often added to ophthalmic blocks to increase tissue permeability and speed up the onset of the block, though it does not affect the maximum safe dose of the anesthetic itself. * **Early signs of toxicity:** Perioral numbness, metallic taste, and tremors.

Question 103: Which of the following is used as an adjuvant therapy for fungal corneal ulcer?

A. Atropine eye drops (Correct Answer)
B. Pilocarpine eye drops
C. Dexamethasone
D. Lidocaine

Explanation: **Explanation:** In the management of a fungal corneal ulcer (keratomycosis), **Atropine (1%) eye drops** serve as a vital adjuvant therapy alongside antifungal agents (like Natamycin or Voriconazole). **Why Atropine is the Correct Answer:** Fungal ulcers often trigger a secondary **anterior uveitis** due to the release of inflammatory toxins. Atropine, a potent cycloplegic and mydriatic, provides three key benefits: 1. **Relief of Ciliary Spasm:** It relaxes the ciliary muscle, significantly reducing the deep, aching pain associated with the ulcer. 2. **Prevention of Posterior Synechiae:** By keeping the pupil dilated, it prevents the iris from adhering to the lens capsule. 3. **Reduction of Exudation:** It stabilizes the blood-aqueous barrier, reducing the inflammatory flare in the anterior chamber. **Analysis of Incorrect Options:** * **B. Pilocarpine:** This is a miotic. It would worsen the pain by causing ciliary muscle contraction and increase the risk of forming small-pupil synechiae. * **C. Dexamethasone:** Steroids are generally **contraindicated** in active fungal ulcers as they suppress the local immune response and promote fungal replication/penetration, potentially leading to corneal perforation. * **D. Lidocaine:** While a local anesthetic, it is not used as an adjuvant therapy. Repeated use of topical anesthetics is toxic to the corneal epithelium and can delay healing. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For filamentous fungi (e.g., *Aspergillus, Fusarium*), the DOC is **Topical Natamycin (5%)**. For *Candida*, **Amphotericin B (0.15%)** is preferred. * **Clinical Sign:** Fungal ulcers are characterized by **feathery margins**, **satellite lesions**, and a **dry, immune ring (Wessely ring)**. * **Cycloplegic of choice:** Atropine is preferred over Tropicamide due to its long duration of action and potent cycloplegic effect.

Question 104: Which of the following vitamins is used in the treatment of optic neuritis?

A. Vitamin A
B. Vitamin B
C. Vitamin D
D. Vitamin C (Correct Answer)

Explanation: **Explanation:** **Optic Neuritis** is an inflammatory, demyelinating condition of the optic nerve, often associated with Multiple Sclerosis. The management of optic neuritis primarily focuses on high-dose intravenous corticosteroids (the Optic Neuritis Treatment Trial protocol). However, supportive therapy involves the use of antioxidants and neuroprotective agents. **Why Vitamin C is the correct answer:** Vitamin C (Ascorbic acid) acts as a potent **antioxidant**. In the acute phase of optic neuritis, there is significant oxidative stress and free radical damage to the myelin sheath and axons. Vitamin C helps neutralize these reactive oxygen species, potentially limiting axonal damage and supporting the recovery of the nerve fibers. In clinical practice, it is often prescribed as an adjuvant to steroids to aid in the reduction of inflammation. **Analysis of Incorrect Options:** * **Vitamin A:** Essential for the synthesis of rhodopsin and the health of the conjunctival/corneal epithelium. Deficiency leads to Xerophthalmia and Night Blindness, but it has no specific role in treating optic nerve inflammation. * **Vitamin B:** While Vitamin B12 (Cobalamin) and B1 (Thiamine) are crucial for nerve health, their deficiency causes **Nutritional/Toxic Optic Neuropathy** (characterized by centrocecal scotoma), not inflammatory optic neuritis. * **Vitamin D:** Though Vitamin D deficiency is linked to the risk of developing Multiple Sclerosis, it is not a standard acute treatment for an episode of optic neuritis. **Clinical Pearls for NEET-PG:** * **Gold Standard Treatment:** IV Methylprednisolone (1g/day for 3 days) followed by oral Prednisolone. * **Classic Sign:** Marcus Gunn Pupil (Relative Afferent Pupillary Defect - RAPD). * **Pulfrich Phenomenon:** A classic symptom where objects moving in a straight line appear to move in an elliptical orbit due to delayed conduction in the affected nerve. * **Uhthoff’s Phenomenon:** Temporary worsening of vision with increased body temperature (e.g., after a hot bath or exercise).

Question 105: What is the mechanism of action of beta-blockers in the management of glaucoma?

A. Increased aqueous outflow
B. Decreased aqueous production (Correct Answer)
C. Opening of the trabecular meshwork
D. All of the above

Explanation: **Explanation:** **Mechanism of Action:** Beta-blockers (e.g., Timolol, Betaxolol) are a mainstay in glaucoma therapy. Their primary mechanism is the **reduction of aqueous humor production** by the ciliary body. Specifically, they block $\beta_2$-receptors located on the non-pigmented ciliary epithelium. This inhibition leads to a decrease in cyclic AMP (cAMP) levels, which reduces the active secretion of aqueous humor into the posterior chamber. **Analysis of Options:** * **Option A & C (Incorrect):** These describe the mechanism of **miotics** (like Pilocarpine) or **prostaglandin analogues** (like Latanoprost). Miotics cause contraction of the ciliary muscle, which pulls on the scleral spur to open the trabecular meshwork (increasing outflow). Prostaglandins primarily increase uveoscleral outflow. Beta-blockers have no significant effect on the drainage pathways. * **Option D (Incorrect):** Since beta-blockers only affect production and not outflow, "All of the above" is incorrect. **High-Yield Clinical Pearls for NEET-PG:** * **Timolol:** The "Gold Standard" non-selective beta-blocker. It is contraindicated in patients with **Asthma/COPD** (due to $\beta_2$ blockade causing bronchospasm) and **Bradycardia/Heart block** (due to $\beta_1$ blockade). * **Betaxolol:** A **cardioselective ($\beta_1$)** blocker. It is safer for patients with respiratory issues but is slightly less efficacious in lowering Intraocular Pressure (IOP) compared to Timolol. * **Levobunolol:** Longest acting topical beta-blocker. * **Side Effects:** Can cause "masked hypoglycemia" in diabetic patients and may worsen depression or impotence.

Question 106: All of the following drugs are used in the management of acute anterior uveitis except?

A. Pilocarpine (Correct Answer)
B. Atropine
C. Timolol
D. Propranolol

Explanation: **Explanation:** The primary goals in managing acute anterior uveitis are to reduce inflammation, prevent the formation of synechiae (adhesions), and relieve ciliary muscle spasms. **Why Pilocarpine is the Correct Answer (The "Except"):** Pilocarpine is a **miotic** (parasympathomimetic). In acute uveitis, it is strictly **contraindicated** for two reasons: 1. **Synechiae Formation:** By constricting the pupil, it increases the surface area of contact between the iris and the lens, promoting the formation of **posterior synechiae**. 2. **Inflammation:** It breaks the blood-aqueous barrier, potentially worsening the inflammatory exudation and increasing pain by inducing ciliary muscle contraction. **Analysis of Other Options:** * **Atropine (Option B):** This is a potent **cycloplegic and mydriatic**. It is the drug of choice because it dilates the pupil (preventing synechiae), puts the ciliary body at rest (relieving pain), and reduces vascular permeability. * **Timolol (Option C):** Uveitis can lead to "Hypertensive Uveitis" due to trabeculitis or inflammatory debris clogging the drainage. Timolol (a topical beta-blocker) is used to manage secondary glaucoma by reducing aqueous production. * **Propranolol (Option D):** While not a primary treatment for uveitis, systemic beta-blockers like Propranolol are occasionally used in the management of associated systemic conditions or secondary ocular hypertension, though Timolol is the preferred topical choice. (Note: In some exam contexts, Propranolol is considered "less relevant" but Pilocarpine remains the definitive "wrong" drug due to its harmful effects). **High-Yield Clinical Pearls for NEET-PG:** * **Mydriatic of choice:** Atropine 1% ointment/drops. * **Short-acting mydriatics:** Phenylephrine or Homatropine are used to "break" freshly formed synechiae by causing pupillary movement. * **Steroids:** Topical steroids (e.g., Prednisolone acetate) are the mainstay to control inflammation. * **Triple Therapy for Uveitis:** Mydriatics + Steroids + Management of secondary glaucoma.

Question 107: Iris cysts are prevented by which medication?

A. Atropine
B. Pilocarpine
C. Phenylephrine (Correct Answer)
D. Ecothiopate

Explanation: **Explanation:** The correct answer is **Phenylephrine**. **Mechanism and Rationale:** Iris cysts (specifically miotic-induced cysts) are a known side effect of long-term use of potent, long-acting cholinesterase inhibitors (miotics) like **Echothiophate**. These cysts form at the pupillary margin due to the proliferation of the iris pigment epithelium. The underlying medical concept is that **Phenylephrine (2.5%)**, a sympathomimetic alpha-1 agonist, acts as a competitive stabilizer. When used concurrently with miotics, it prevents the hypertrophy and cystic changes of the pigment epithelium without neutralizing the pressure-lowering effect of the miotic. **Analysis of Incorrect Options:** * **Atropine (A):** This is a potent parasympatholytic (mydriatic-cycloplegic). While it dilates the pupil, it is not used to prevent cysts caused by miotics; in fact, its clinical action is the polar opposite of the drugs that cause the cysts. * **Pilocarpine (B):** This is a direct-acting miotic. While it can occasionally cause iris cysts, they are much more common with long-acting indirect miotics. It does not prevent them. * **Echothiophate (D):** This is an irreversible cholinesterase inhibitor and is the **primary cause** of these iris cysts, not the preventive agent. **Clinical Pearls for NEET-PG:** * **Echothiophate** is the most common culprit for iris cysts in children being treated for accommodative esotropia. * **Phenylephrine 2.5%** is the specific concentration used to prevent these cysts. * **Other side effects of Echothiophate:** Retinal detachment, cataract formation (anterior subcapsular), and prolonged apnea if succinylcholine is administered during anesthesia (due to depleted plasma pseudocholinesterase).

Question 108: Which medication is known to induce iris cyst formation?

A. Atropine
B. Pilocarpine (Correct Answer)
C. Latanoprost
D. Timolol

Explanation: **Explanation:** **Pilocarpine** is a direct-acting parasympathomimetic (miotic) that acts on the muscarinic receptors of the iris sphincter muscle. A well-documented side effect of long-term or high-dose miotic therapy, particularly with potent agents like Pilocarpine or Echothiophate, is the formation of **iris pigment epithelial cysts**. These cysts typically occur at the pupillary margin and are caused by the continuous, intense contraction of the iris muscles, which leads to the proliferation and cystic entrapment of the pigment epithelium. In children, these cysts can become large enough to obstruct the visual axis. **Analysis of Incorrect Options:** * **Atropine:** This is a parasympatholytic (mydriatic/cycloplegic). It causes pupillary dilation and paralysis of accommodation, rather than the pupillary constriction associated with cyst formation. * **Latanoprost:** A Prostaglandin analogue used in glaucoma. Its characteristic iris-related side effect is **increased iris pigmentation** (heterochromia) due to increased melanin synthesis, not cyst formation. * **Timolol:** A topical Beta-blocker that reduces aqueous humor production. It has no significant effect on the iris musculature or the pigment epithelium. **High-Yield Clinical Pearls for NEET-PG:** * **Prevention:** Iris cysts induced by miotics can often be prevented or minimized by the concurrent administration of **Phenylephrine 2.5%**. * **Other Pilocarpine Side Effects:** Retinal detachment (due to ciliary body contraction pulling the retina), brow ache (ciliary spasm), and miosis-induced night blindness. * **Drug of Choice:** Pilocarpine remains the drug of choice for **Acute Angle Closure Glaucoma** (once IOP is lowered) to pull the iris away from the angle.

Question 109: Ranibizumab is a monoclonal antibody against which of the following targets?

A. IL-6
B. CD-20
C. VEGF (Correct Answer)
D. EGFR

Explanation: **Explanation:** **Ranibizumab** is a recombinant humanized monoclonal antibody fragment (Fab) designed to bind and inhibit **Vascular Endothelial Growth Factor A (VEGF-A)**. VEGF is a potent cytokine that promotes angiogenesis (new blood vessel formation) and increases vascular permeability. In ophthalmology, excessive VEGF levels lead to pathological neovascularization and macular edema. By neutralizing VEGF, Ranibizumab prevents the growth of abnormal vessels and reduces leakage, making it a cornerstone in treating **Wet Age-related Macular Degeneration (AMD)**, Diabetic Macular Edema (DME), and Retinal Vein Occlusion (RVO). **Analysis of Incorrect Options:** * **A. IL-6:** Interleukin-6 is a pro-inflammatory cytokine. Inhibitors like **Tocilizumab** are used in Rheumatoid Arthritis and Giant Cell Arteritis, but not as primary anti-angiogenic agents in the eye. * **B. CD-20:** This is a surface antigen on B-cells. **Rituximab** is the monoclonal antibody targeting CD-20, used in lymphomas and certain autoimmune conditions (e.g., Ocular Cicatricial Pemphigoid). * **D. EGFR:** Epidermal Growth Factor Receptor inhibitors like **Cetuximab** are used in treating systemic malignancies (e.g., colorectal cancer), not retinal vascular diseases. **High-Yield Clinical Pearls for NEET-PG:** * **Ranibizumab vs. Bevacizumab:** Ranibizumab is a Fab fragment (smaller molecule), whereas Bevacizumab is a full-length antibody. * **Aflibercept:** Another common agent, acts as a "VEGF Trap" by binding to VEGF-A, VEGF-B, and Placental Growth Factor (PlGF). * **Route of Administration:** These drugs are administered via **intravitreal injection** to ensure high local concentration and minimal systemic side effects. * **Common Indication:** The most frequent "high-yield" indication tested is **Exudative (Wet) AMD**.

Question 110: Which of the following medications causes lid retraction?

A. Bimatoprost
B. Latanoprost
C. Brimonidine
D. Apraclonidine (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Apraclonidine** **Mechanism of Action:** Apraclonidine is a potent **alpha-1 and alpha-2 adrenergic agonist**. Lid retraction occurs due to its stimulatory effect on the **Müller’s muscle**, which is a smooth muscle in the upper eyelid innervated by the sympathetic nervous system. When alpha-1 receptors are stimulated, the muscle contracts, leading to an elevation of the upper eyelid (widening of the palpebral fissure). **Clinical Utility:** This side effect is utilized diagnostically in the **Apraclonidine Test for Horner’s Syndrome**. In a normal eye, it has minimal effect, but in Horner’s (due to denervation supersensitivity), it causes significant lid elevation, helping confirm the diagnosis. **Why other options are incorrect:** * **A & B (Bimatoprost and Latanoprost):** These are Prostaglandin Analogues (PGAs). A classic side effect of PGAs is **Prostaglandin-associated Periorbitopathy (PAP)**, which causes deepening of the upper eyelid sulcus and **ptosis** (drooping), rather than retraction. They also cause eyelash growth and iris hyperpigmentation. * **C (Brimonidine):** While also an alpha-agonist, Brimonidine is highly selective for **alpha-2 receptors**. It lacks the significant alpha-1 activity required to stimulate Müller’s muscle; therefore, it does not typically cause lid retraction. **High-Yield Clinical Pearls for NEET-PG:** * **Apraclonidine:** Primarily used to prevent post-laser (YAG capsulotomy/Iridotomy) IOP spikes. * **Tachyphylaxis:** Long-term use of Apraclonidine is limited by a high incidence of follicular conjunctivitis and loss of efficacy (tachyphylaxis). * **Mnemonic:** **A**praclonidine **A**scends the lid (Retraction); **P**rostaglandins **P**recipitate the lid (Ptosis).

Practice by Chapter

Ocular Pharmacokinetics

Practice Questions

Anti-infective Agents

Practice Questions

Anti-inflammatory Drugs

Practice Questions

Antiglaucoma Medications

Practice Questions

Mydriatics and Cycloplegics

Practice Questions

Ocular Lubricants

Practice Questions

Anti-VEGF Agents

Practice Questions

Ocular Diagnostic Agents

Practice Questions

Anesthetics in Ophthalmology

Practice Questions

Preservatives and Their Effects

Practice Questions

Ocular Toxicology

Practice Questions

Novel Drug Delivery Systems

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free